Screening epitope peptides based on a phage-displayed random peptide and peptide microarrays to contribute to improving the diagnostic efficiency of systemic lupus erythematosus
Immunology Letters · 2023
DOI: 10.1016/j.imlet.2023.05.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology Letters, 2023. Verfasst von Xin Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Medicine Center, Nanfang Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Autoimmune Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Special Project for Research and Development in Key areas of Guangdong Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Systemic lupus erythematosus (SLE) is one of the most common autoimmune diseases in China. At present, there are hundreds of autoantibodies in SLE patients; however, only a dozen of the autoantibodies can be routinely detected, and the available diagnostic antibodies are not sufficient for diagnosis or differential diagnosis of SLE patients with atypical clinical manifestations or other autoimmune diseases. Therefore, it is necessary to find new diagnostic markers to improve the diagnostic effect of SLE. METHODS: The displayed random peptide library and peptide microarray were combined to identify SLE-related epitope peptides. A case-control design was used. The IgG antibodies in the sera from SLE patients, healthy controls, and other autoimmune disease controls underwent a reaction with the phage-display random peptide library, respectively. Selected epitope peptides were used to construct a peptide chip. A total of 644 serum samples (including 296 SLE patients, 168 disease controls, and 180 healthy controls) were used for further screening and verification. Peptides with an area under the curve (AUC) > 0.650 were further verified by ELISA. Finally, 500 serum samples (including 200 SLE patients, 150 disease controls, and 150 healthy controls) were used to verify and evaluate the diagnostic and differential diagnostic efficacy of the selected peptides. RESULTS: After the previous screening, five epitope peptides (SLE_P19, SLE_P20, SLE_P27, SLE_P28, and SLE_P29) may have potential as SLE diagnostic markers. Additionally, SLE_P27 was superior to the other four peptides in the diagnosis and differential diagnosis of SLE and rheumatoid arthritis (RA). The AUC of SLE_P27 was 0.938, the sensitivity was 76.00%, the specificity was 92.70%, the positive likelihood ratio was 10.411, the negative likelihood ratio was 0.259, and the accuracy was 84.40%. The diagnostic efficacy of SLE can be increased by combining the five selected peptides with the anti-double stranded DNA antibody (anti-dsDNA) and anti-Smith antibodies (anti-Sm). CONCLUSIONS: In this study, we identified five peptides that may serve as potential biomarkers for SLE diagnosis using the strategy of combining the displayed random peptide library with the peptide microarray. The combination of selected peptides and existing autoantibodies can significantly improve the diagnostic efficiency. These specific peptides are expected to be new diagnostic markers for SLE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory Medicine Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- Department of Clinical Laboratory, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
- Laboratory Medicine Center, Nanfang Hospital, Southern Medical University, Guangzhou, China; Guangzhou Huayin Medical laboratory center. LTD, Guangzhou, China. Electronic address: qyr@smu.edu.cn.
Förderung
- Special Project for Research and Development in Key areas of Guangdong Province
- National Natural Science Foundation of China
Zitieren
APA
Li, X., Wang, H. X., Yin, X., Li, X., Li, H., Zhang, X., Wang, Z., & Qiu, Y. R. (2023). Screening epitope peptides based on a phage-displayed random peptide and peptide microarrays to contribute to improving the diagnostic efficiency of systemic lupus erythematosus. Immunology Letters. https://doi.org/10.1016/j.imlet.2023.05.008
Vancouver
Li X, Wang HX, Yin X, Li X, Li H, Zhang X, et al. Screening epitope peptides based on a phage-displayed random peptide and peptide microarrays to contribute to improving the diagnostic efficiency of systemic lupus erythematosus. Immunology Letters. 2023. doi:10.1016/j.imlet.2023.05.008
BibTeX
@article{Li2023,
author = {Li, Xin and Wang, Hong-Xia and Yin, Xiaofeng and Li, Xueheng and Li, Haixia and Zhang, Xiaohe and Wang, Zheng and Qiu, Yu-Rong},
title = {Screening epitope peptides based on a phage-displayed random peptide and peptide microarrays to contribute to improving the diagnostic efficiency of systemic lupus erythematosus},
journal = {Immunology Letters},
year = {2023},
doi = {10.1016/j.imlet.2023.05.008}
}
EUVIMED